NGM Biopharmaceuticals, Inc. carries a market capitalization of 128.53M, placing it among publicly traded companies globally.
| Market Cap | 128.53M |
| Enterprise Value | N/A |
NGM Biopharmaceuticals, Inc.'s stock has declined approximately -60.91371% over the past 52 weeks. The 50-day moving average sits at 1.55, while the 200-day moving average is 1.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60.91371% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 1.49 |
| Average Volume (20 Days) | N/A |